Eckert & Ziegler Strahlen- und Medizintechnik AG
EUZ | F
Overview
Corporate Details
- ISIN(s):
- DE0005659700
- LEI:
- 391200EUDABLUKXCKG48
- Country:
- Germany
- Address:
- Robert-Rössle-Str. 10, 13125 Berlin
- Website:
- https://www.ezag.com/startseite/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The two business segments are: Medical and Isotope Products. Eckert & Ziegler was founded in 1997 as a holding company.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Eckert & Ziegler Strahlen- und Medizintechnik AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-08 07:45 |
Earnings Release
Eckert & Ziegler: Further Increase in Earnings in the First Half of 2025
|
English | 7.7 KB | |
| 2025-08-08 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 3.3 MB | |
| 2025-08-05 11:50 |
Share Issue/Capital Change
Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to …
|
English | 6.9 KB | |
| 2025-07-29 14:00 |
Regulatory News Service
Eckert & Ziegler Selected as US Manufacturer for Archeus Next-Generation Radiop…
|
English | 7.4 KB | |
| 2025-07-28 13:37 |
Declaration of Voting Results & Voting Rights Announcements
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 4.5 KB | |
| 2025-07-15 14:00 |
Regulatory News Service
Eckert & Ziegler: Outstanding Training Quality Once Again Awarded
|
English | 7.4 KB | |
| 2025-06-18 16:05 |
Post-Annual General Meeting Information
Annual General Meeting of Eckert & Ziegler SE Approves Dividend of EUR 0.50
|
English | 6.3 KB | |
| 2025-06-05 10:00 |
Regulatory News Service
Eckert & Ziegler: Illuccix PSMA-PET Imaging Agent Receives Approval in Germany
|
English | 7.1 KB | |
| 2025-05-30 10:00 |
Regulatory News Service
Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
|
English | 8.0 KB | |
| 2025-05-23 10:00 |
Regulatory News Service
Eckert & Ziegler Wins Best Managed Companies Award for the Second Time
|
English | 7.1 KB | |
| 2025-05-13 07:45 |
Earnings Release
Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year …
|
English | 7.6 KB | |
| 2025-05-13 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 1.7 MB | |
| 2025-05-07 15:05 |
Pre-Annual General Meeting Information
Eckert & Ziegler SE: Bekanntmachung der Einberufung zur Hauptversammlung am 18.…
|
German | 85.4 KB | |
| 2025-05-02 21:13 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.3 KB | |
| 2025-04-28 00:00 |
Annual Report
Annual financial report 2024 (PDF)
|
English | 3.6 MB |
Automate Your Workflow. Get a real-time feed of all Eckert & Ziegler Strahlen- und Medizintechnik AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Eckert & Ziegler Strahlen- und Medizintechnik AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-08-30 | Eckert, Dr. Andreas | Supervisory board | Sell | None | 1,526,400.00 EUR |
| 2023-08-30 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,526,400.00 EUR |
| 2023-08-11 | Perschmann, Frank | Supervisory board | Buy | None | 16,600.00 EUR |
| 2023-01-13 | NEON Equity AG | Close relation | Buy | None | 2,115.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 57,402.00 EUR |
| 2023-01-12 | Blunck, Dr. Thomas | Board | Sell | None | 32,160.00 EUR |
| 2023-01-11 | Bouterfa, Dr. Hakim | Board | Buy | None | 124,800.00 EUR |
| 2022-12-21 | Eckert Wagniskapital und Frühphasenfinanzierung GmbH | Close relation | Buy | None | 1,432,800.00 EUR |
| 2022-12-06 | Maennig, Prof. Dr. Wolfgang | Supervisory board | Buy | None | 72,745.31 EUR |
| 2022-12-05 | Carpio GmbH | Close relation | Buy | None | 73,826.53 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BSF ENTERPRISE PLC | United Kingdom | BSFA | |
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA |